These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22849622)

  • 1. κ-Casein-based hierarchical suprastructures and their use for selective temporal and spatial control over neuronal differentiation.
    Chun J; Bhak G; Lee SG; Lee JH; Lee D; Char K; Paik SR
    Biomacromolecules; 2012 Sep; 13(9):2731-8. PubMed ID: 22849622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of fibril formation of bovine kappa-casein indicate a conformational rearrangement as a critical step in the process.
    Leonil J; Henry G; Jouanneau D; Delage MM; Forge V; Putaux JL
    J Mol Biol; 2008 Sep; 381(5):1267-80. PubMed ID: 18616951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid hydrogel derived from curly protein fibrils of alpha-synuclein.
    Bhak G; Lee S; Park JW; Cho S; Paik SR
    Biomaterials; 2010 Aug; 31(23):5986-95. PubMed ID: 20471079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dissociated form of kappa-casein is the precursor to its amyloid fibril formation.
    Ecroyd H; Thorn DC; Liu Y; Carver JA
    Biochem J; 2010 Jul; 429(2):251-60. PubMed ID: 20441567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid fibril formation by bovine milk kappa-casein and its inhibition by the molecular chaperones alphaS- and beta-casein.
    Thorn DC; Meehan S; Sunde M; Rekas A; Gras SL; MacPhee CE; Dobson CM; Wilson MR; Carver JA
    Biochemistry; 2005 Dec; 44(51):17027-36. PubMed ID: 16363816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental influences on bovine kappa-casein: reduction and conversion to fibrillar (amyloid) structures.
    Farrell HM; Cooke PH; Wickham ED; Piotrowski EG; Hoagland PD
    J Protein Chem; 2003 Apr; 22(3):259-73. PubMed ID: 12962326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid fibrils from readily available sources: milk casein and lens crystallin proteins.
    Ecroyd H; Garvey M; Thorn DC; Gerrard JA; Carver JA
    Methods Mol Biol; 2013; 996():103-17. PubMed ID: 23504420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrillar beta-lactoglobulin gels: Part 1. Fibril formation and structure.
    Gosal WS; Clark AH; Ross-Murphy SB
    Biomacromolecules; 2004; 5(6):2408-19. PubMed ID: 15530058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine oxidation enhances κ-casein amyloid fibril formation.
    Koudelka T; Dehle FC; Musgrave IF; Hoffmann P; Carver JA
    J Agric Food Chem; 2012 Apr; 60(16):4144-55. PubMed ID: 22443319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid fibril formation by bovine milk alpha s2-casein occurs under physiological conditions yet is prevented by its natural counterpart, alpha s1-casein.
    Thorn DC; Ecroyd H; Sunde M; Poon S; Carver JA
    Biochemistry; 2008 Mar; 47(12):3926-36. PubMed ID: 18302322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-like fibrils formed from intrinsically disordered caseins: physicochemical and nanomechanical properties.
    Pan K; Zhong Q
    Soft Matter; 2015 Aug; 11(29):5898-904. PubMed ID: 26112282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermoreversible protein hydrogel as cell scaffold.
    Yan H; Saiani A; Gough JE; Miller AF
    Biomacromolecules; 2006 Oct; 7(10):2776-82. PubMed ID: 17025352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Milk Constituents and Crowding Agents on Amyloid Fibril Formation by κ-Casein.
    Liu J; Dehle FC; Liu Y; Bahraminejad E; Ecroyd H; Thorn DC; Carver JA
    J Agric Food Chem; 2016 Feb; 64(6):1335-43. PubMed ID: 26807595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional molecular modeling of bovine caseins: kappa-casein.
    Kumosinski TF; Brown EM; Farrell HM
    J Dairy Sci; 1991 Sep; 74(9):2879-87. PubMed ID: 1779047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casein-based formulations as promising controlled release drug delivery systems.
    Elzoghby AO; El-Fotoh WS; Elgindy NA
    J Control Release; 2011 Aug; 153(3):206-16. PubMed ID: 21338636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel casein hydrogels: formation, structure and controlled drug release.
    Song F; Zhang LM; Shi JF; Li NN
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):142-8. PubMed ID: 20434318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoporous protein matrix made of amyloid fibrils of β2-microglobulin.
    Ahn M; Kang S; Koo HJ; Lee JH; Lee YS; Paik SR
    Biotechnol Prog; 2010; 26(6):1759-64. PubMed ID: 20572297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species.
    Rekas A; Jankova L; Thorn DC; Cappai R; Carver JA
    FEBS J; 2007 Dec; 274(24):6290-304. PubMed ID: 18005258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and release of verapamil hydrochloride from polycaprolactone/acrylic acid (PCL/AA) hydrogels.
    Hanif M; Ranjha NM; Shoaib MH; Mudasser J; Yousuf RI; Khan A; Zia-Ul-Haq M
    Pak J Pharm Sci; 2011 Oct; 24(4):503-11. PubMed ID: 21959812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional supra-self-assembly of human serum albumin under amyloid-like-forming solution conditions.
    Juárez J; Taboada P; Goy-López S; Cambón A; Madec MB; Yeates SG; Mosquera V
    J Phys Chem B; 2009 Sep; 113(36):12391-9. PubMed ID: 19681594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.